Studies of delayed-release mesalazine in the treatment of ulcerative colitis

Studies of delayed-release mesalazine in the treatment of ulcerative colitis

Bibliographic Details
Main Author:	Riley, Stuart Anthony
Published:	University of Leeds 2004
Subjects:	616.3447061
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.413189

Similar Items

MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS
by: I. G. Bakulin, et al.
Published: (2017-11-01)

Mesalazine-induced myopericarditis in a patient with ulcerative colitis
by: Jalal Asadi, et al.
Published: (2017-12-01)

Mesalazine-induced intersticial pneumonitis in patients with ulcerative colitis
by: Elena Prado Mel, et al.
Published: (2016-01-01)

Observation on the efficacy of Etiasa in combined with mesalazine suppository in the treatment of ulcerative colitis
by: Min Zhao, et al.
Published: (2016-06-01)

Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis
by: O. V. Knyazev, et al.
Published: (2021-05-01)

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine
by: Giuseppe Frieri, et al.
Published: (2017-10-01)

What is the real-life maintenance mesalazine dose in ulcerative colitis?
by: Alicia Algaba, et al.

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
by: Keiji Yagisawa, et al.
Published: (2019-01-01)

Mesalazine induced focal segmental glomerulosclerosis in a patient with ulcerative colitis
by: Fatih Yilmaz, et al.
Published: (2020-01-01)

Lung disease/pneumonitis in a patient with ulcerative colitis due to mesalazine
by: O. A. Sablin, et al.
Published: (2021-02-01)

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
by: Keiji Yagisawa, et al.
Published: (2020-07-01)

Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis
by: Böhm SK, et al.
Published: (2014-09-01)

Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine
by: Mittendorf Thomas, et al.
Published: (2011-07-01)

The effectiveness of mesalazine therapy of ulcerative colitis of moderate severity in real clinical practice
by: O. V. Knyazev, et al.
Published: (2019-10-01)

Recurrent Eosinophilic Pneumonia Associated with Mesalazine Suppository in a Patient with Ulcerative Colitis
by: Myoungrin Park, et al.
Published: (2019-04-01)

Efficacy of Combined Mesalazine Plus Corticosteroid Enemas for Diversion Colitis after Subtotal Colectomy for Ulcerative Colitis
by: Satohiro Matsumoto, et al.
Published: (2016-05-01)

Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis
by: Haotian Chen, et al.
Published: (2021-06-01)

Clinical and economic efficiency of multi-matrix mesalazine in ulcerative colitis treatment in the healthcare system of the Republic of Kazakhstan
by: Alima Almadiyeva, et al.
Published: (2019-06-01)

Mesalazin-induced eosinophilic pneumonia in a 15-year-old boy with ulcerative colitis
by: G. N. Yankinа, et al.
Published: (2019-10-01)

ACOS: Clinical and functional features The Russian formulation mesalazine (kansalazine) in the therapy of ulcerative colitis
by: E A Sobko, et al.
Published: (2017-12-01)

Effect of mesalazine combined with tanshinone on inflammatory cytokines and hypercoagulation status in patients with ulcerative colitis
by: De-Shan Xiong, et al.
Published: (2016-11-01)

Acute Pancreatitis due to pH-Dependent Mesalazine That Occurred in the Course of Ulcerative Colitis
by: Yoshinori Arai, et al.
Published: (2011-10-01)

Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
by: Haruhiko Ogata, et al.
Published: (2017-07-01)

Clinical observation of Baitou Weng Decoction combined with mesalazine sustained-release tablets in treating heat-toxic and smoldering ulcerative colitis
by: Qian-Zhang Ma, et al.
Published: (2019-06-01)

DECISION TREE CONSTRUCTION AND COST-EFFECTIVENESS ANALYSIS OF TREATMENT OF ULCERATIVE COLITIS WITH PENTASA®MESALAZINE 2 G SACHET
by: Alvaro Mitsunori NISHIKAWA, et al.

Clinical effect and effect of Mesalazine combined with Bifico on oxidatives stress and cytokines in patients with ulcerative colitis
by: Zhi-Gang Huang, et al.
Published: (2016-03-01)

Efficacy of a pH-dependent controlled-release mesalazine based on clinical and endoscopic assessment for ulcerative colitis: a retrospective cohort study
by: Matsumoto S, et al.
Published: (2015-07-01)

Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
by: Kousaku Kawashima, et al.
Published: (2014-01-01)

Ulcerative Colitis Activity Presenting as Fever of Unknown Origin, in a Patient with Longstanding Disease under Continuous Treatment with Mesalazine
by: Panagiota Voukelatou, et al.
Published: (2016-01-01)

Clinical study on the efficacy of mesalazine and live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in the treatment of ulcerative colitis
by: Hai-Ping Hu, et al.
Published: (2016-08-01)

Comparative Transcriptomic Analysis Reveals the Immunosuppressive Targets of Mesalazine in Dextran Sulfate Sodium-Induced Ulcerative Colitis
by: Rong Li, et al.
Published: (2021-08-01)

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
by: Seong Ran Jeon
Published: (2018-04-01)

Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
by: Haruhiko Ogata, et al.
Published: (2017-07-01)

Immunological studies in ulcerative colitis and crohn's disease
by: Jewell, D. P.
Published: (1972)

Prebiotic applications in health and ulcerative colitis
by: Kolida, Sofia
Published: (2003)

Colonic mucosal microbiota in ulcerative colitis
by: Thomson, John M.
Published: (2011)

Colorectal cancer in patients with ulcerative colitis
by: Eaden, Jayne Alison
Published: (2000)

Psychological stress and hypnosis in ulcerative colitis
by: Mawdsley, Joel Evan David
Published: (2008)

Improving colonscopic surveillance for colorectal cancer in ulcerative colitis
by: Rutter, Matthew David
Published: (2005)

The effects of interleukin-8 on neutrophil function in ulcerative colitis
by: Nichol, Ian Edward
Published: (2001)

Cannot write session to /tmp/vufind_sessions/sess_s8r0qt0s3kbl0qpi7p7gnvjhc9